Is increased arterial stiffness a cause or consequence of atherosclerosis?

Atherosclerosis

Volumn 249, Issue , 2016, Pages 226-227

  Hansen, Laura ^a   Taylor, W Robert ^a,b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; COLLAGEN; ELASTIN; METALLOPROTEINASE;

ARTERIAL STIFFNESS; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL COMPLIANCE; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; HUMAN; HYPERTENSION; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; RISK FACTOR; VASCULAR RESISTANCE;

ATHEROSCLEROSIS; HUMANS; RISK FACTORS; VASCULAR RESISTANCE; VASCULAR STIFFNESS;

EID: 84964669350     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.04.014     Document Type: Note

References (23)

1. [1] Mitchell, G.F., Hwang, S.J., Vasan, R.S., Larson, M.G., Pencina, M.J., Hamburg, N.M., Vita, J.A., Levy, D., Benjamin, E.J., Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 121:4 (2010), 505–511, 10.1161/circulationaha.109.886655 Epub 2010/01/20. PubMed PMID: 20083680; PMCID: Pmc2836717.
2. [2] Willum-Hansen, T., Staessen, J.A., Torp-Pedersen, C., Rasmussen, S., Thijs, L., Ibsen, H., Jeppesen, J., Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 113:5 (2006), 664–670, 10.1161/circulationaha.105.579342 Epub 2006/02/08. PubMed PMID: 16461839.
3. [3] Jankowski, P., Kawecka-Jaszcz, K., Czarnecka, D., Brzozowska-Kiszka, M., Styczkiewicz, K., Loster, M., Kloch-Badełek, M., Wiliński, J., Curyło, A.M., Dudek, D., Pressure obotAB, Group SS. Pulsatile but not steady component of blood pressure predicts cardiovascular events in coronary patients. Hypertension 51:4 (2008), 848–855, 10.1161/hypertensionaha.107.101725.
4. [4] Mattace-Raso, F.U.S., Van Der Cammen, T.J.M., Hofman, A., Van Popele, N.M., Bos, M.L., Schalekamp, M.A.D.H., Asmar, R., Reneman, R.S., Hoeks, A.P.G., Breteler, M.M.B., Witteman, J.C.M., Arterial stiffness and risk of coronary heart disease and stroke: The Rotterdam Study. Circulation 113:5 (2006), 657–663, 10.1161/CIRCULATIONAHA.105.555235.
5. [5] Vlachopoulos, C., Aznaouridis, K., Stefanadis, C., Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 55:13 (2010), 1318–1327, 10.1016/j.jacc.2009.10.061 Epub 2010/03/27. PubMed PMID: 20338492.
6. [6] Blacher, J., Asmar, R., Djane, S., London, G.M., Safar, M.E., Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 33:5 (1999), 1111–1117, 10.1161/01.hyp.33.5.1111.
7. [7] Domanski, M., Norman, J., Wolz, M., Mitchell, G., Pfeffer, M., Cardiovascular risk assessment using pulse pressure in the first national health and nutrition examination survey (NHANES I). Hypertension 38:4 (2001), 793–797, 10.1161/hy1001.092966.
8. [8] van Popele, N.M., Grobbee, D.E., Bots, M.L., Asmar, R., Topouchian, J., Reneman, R.S., Hoeks, A.P., van der Kuip, D.A., Hofman, A., Witteman, J.C., Association between arterial stiffness and atherosclerosis. The Rotterdam Study. Stroke 32:2 (2001), 454–460.
9. [9] Oberoi, S., Schoepf, U.J., Meyer, M., Henzler, T., Rowe, G.W., Costello, P., Nance, J.W., Progression of arterial stiffness and coronary atherosclerosis: longitudinal evaluation by cardiac CT. AJR Am. J. Roentgenol. 200:4 (2013), 798–804, 10.2214/ajr.12.8653 Epub 2013/03/26. PubMed PMID: 23521451.
10. [10] Palombo, C., Kozakova, M., Arterial stiffness, atherosclerosis and cardiovascular risk: Pathophysiologic mechanisms and emerging clinical indications. Vasc. Pharmacol. 77 (2016), 1–7, 10.1016/j.vph.2015.11.083.
11. [11] Maedeker, J.A., Stoka, K.V., Bhayani, S.A., Gardner, W.S., Bennett, L., Procknow, J.D., Staiculescu, M.C., Walji, T.A., Craft, C.S., Wagenseil, J.E., Hypertension and decreased aortic compliance due to reduced elastin amounts do not increase atherosclerotic plaque accumulation in Ldlr-/- mice. Atherosclerosis, 2016 (in press).
12. [12] Birukov, K.G., Cyclic stretch, reactive oxygen species, and vascular remodeling. Antioxidants Redox Signal. 11:7 (2009), 1651–1667, 10.1089/ars.2008.2390 Epub 2009/02/04. PubMed PMID: 19186986; PMCID: Pmc2842585.
13. [13] Bennett, M.R., Sinha, S., Owens, G.K., Vascular Smooth Muscle Cells in Atherosclerosis. Circulation Res. 118:4 (2016), 692–702, 10.1161/circresaha.115.306361.
14. [14] Owens, G.K., Kumar, M.S., Wamhoff, B.R., Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84:3 (2004), 767–801, 10.1152/physrev.00041.2003.
15. [15] Davignon, J., Ganz, P., Role of endothelial dysfunction in atherosclerosis. Circulation 109:23 Suppl. 1 (2004), III-27–III-32, 10.1161/01.CIR.0000131515.03336.f8.
16. [16] Chatzizisis, Y.S., Coskun, A.U., Jonas, M., Edelman, E.R., Feldman, C.L., Stone, P.H., Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J. Am. Coll. Cardiol. 49:25 (2007), 2379–2393, 10.1016/j.jacc.2007.02.059 Epub 2007/06/30. PubMed PMID: 17599600.
17. [17] Van Herck, J.L., De Meyer, G.R.Y., Martinet, W., Van Hove, C.E., Foubert, K., Theunis, M.H., Apers, S., Bult, H., Vrints, C.J., Herman, A.G., Impaired fibrillin-1 function promotes features of plaque instability in apolipoprotein E–deficient mice. Circulation 120:24 (2009), 2478–2487, 10.1161/circulationaha.109.872663.
18. [18] Wu, C.F., Liu, P.Y., Wu, T.J., Hung, Y., Yang, S.P., Lin, G.M., Therapeutic modification of arterial stiffness: An update and comprehensive review. World J. Cardiol. 7:11 (2015), 742–753, 10.4330/wjc.v7.i11.742 Epub 2015/12/05. PubMed PMID: 26635922; PMCID: Pmc4660469.
19. [19] Wolffenbuttel, B.H., Boulanger, C.M., Crijns, F.R., Huijberts, M.S., Poitevin, P., Swennen, G.N., Vasan, S., Egan, J.J., Ulrich, P., Cerami, A., Levy, B.I., Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc. Natl. Acad. Sci. U. S. A. 95:8 (1998), 4630–4634 Epub 1998/05/16. PubMed PMID: 9539789; PMCID: Pmc22541.
20. [20] Cheng, G., Wang, L.L., Long, L., Liu, H.Y., Cui, H., Qu, W.S., Li, S., Beneficial effects of C36, a novel breaker of advanced glycation end products cross-links, on the cardiovascular system of diabetic rats. Br. J. Pharmacol. 152:8 (2007), 1196–1206, 10.1038/sj.bjp.0707533 Epub 2007/10/30. PubMed PMID: 17965740; PMCID: Pmc2189992.
21. [21] Smulyan, H., Mookherjee, S., Safar, M.E., The two faces of hypertension: role of aortic stiffness. J. Am. Soc. Hypertens. 10:2 (2016), 175–183, 10.1016/j.jash.2015.11.012.
22. [22] Kass, D.A., Shapiro, E.P., Kawaguchi, M., Capriotti, A.R., Scuteri, A., deGroof, R.C., Lakatta, E.G., Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 104:13 (2001), 1464–1470 Epub 2001/09/26. PubMed PMID: 11571237.
23. [23] Wang, M., Zhang, J., Telljohann, R., Jiang, L., Wu, J., Monticone, R.E., Kapoor, K., Talan, M., Lakatta, E.G., Chronic matrix metalloproteinase inhibition retards age-associated arterial proinflammation and increase in blood pressure. Hypertension 60:2 (2012), 459–466, 10.1161/hypertensionaha.112.191270 Epub 2012/06/13. PubMed PMID: 22689745; PMCID: Pmc3537179.